论文部分内容阅读
同种异体肾移植术后早期发生急性排斥反应时 ,如果受者体内出现新的针对供者特异性的HLA抗体 ,通常称为急性体液性排斥反应 (acutehumoralrejection ,AHR) ,其发病率为 4 6%~ 6 8%。AHR临床表现为移植术后早期急性难治性排斥反应或加速性排斥
When an acute rejection occurs early after allogeneic kidney transplantation, a new HLA-specific donor-specific antibody, commonly referred to as acute humoral rejection (AHR), is present at an incidence of 46 % ~ 6 8%. AHR clinical manifestations of early post-transplant acute refractory rejection or accelerated rejection